Major Force in the Self-Administered Parenteral Market 2025: Chronic Diseases Fueling Self-Administered Parenteral Market Expansion

How Will the Self-Administered Parenteral Market Grow, and What Is the Projected Market Size?
The self-administered parenteral market has experienced strong growth in recent years. It will rise from $24.57 billion in 2024 to $26.04 billion in 2025, at a CAGR of 6.0%. This growth is driven by the rise in chronic diseases, the aging population, government initiatives, patient education and support programs, and the increasing incidences of bone disorders.

The self-administered parenteral market is expected to grow steadily, reaching $31.18 billion by 2029, at a CAGR of 4.6%. This growth is attributed to an increasing preference for home healthcare, the rise of telemedicine and remote monitoring, patient education, and the growing personalized medicine sector. Trends include the integration of digital health solutions, customized drug delivery systems, emerging targeted therapies, and advancements in biologics.

What Key Elements Are Boosting Growth in the Self-Administered Parenteral Market?
The rising prevalence of chronic diseases is expected to propel the growth of the self-administered parenteral market. Chronic diseases are long-term medical conditions that develop gradually and require ongoing treatment and management. Self-administered parenteral therapies enable patients to manage their treatment independently, improving medication adherence compared to oral drugs. For instance, in January 2023, the National Institutes of Health, a U.S. government agency, projected that among individuals aged 50 and older, the number of people with at least one chronic illness would surge by 99.5%, increasing from 71.52 million in 2020 to 142.66 million by 2050. Thus, the increasing burden of chronic diseases is driving the growth of the self-administered parenteral market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

Who Are the Major Industry Players Fueling Self-Administered Parenteral Market Expansion?
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG

Which Key Developments Are Influencing the Self-Administered Parenteral Market?
Companies in the self-administered parenteral market are developing innovative products like the UDENYCA autoinjector to improve patient accessibility and treatment options. For example, in May 2023, Coherus BioSciences Inc., a US-based biotech firm, launched the UDENYCA autoinjector in the US. This self-administered, single-dose, prefilled autoinjector offers patients a convenient option for pegfilgrastim delivery, featuring an intuitive push-on-skin activation mechanism for fast and reliable administration.

How Is the Segmentation of the Self-Administered Parenteral Market Defined?
The self-administered parenteral market covered in this report is segmented -

1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors
4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

What Is the Leading Region in the Self-Administered Parenteral Market?
North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Self-Administered Parenteral Global Market Report?

- Market Size Analysis: Analyze the Self-Administered Parenteral Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Self-Administered Parenteral Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Self-Administered Parenteral Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Self-Administered Parenteral Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.